NOV 05, 2020 7:15 AM PST

Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection

WRITTEN BY: Heba El Wassef

Our knowledge of COVID-19 or SARS-CoV-2 is increasing every day, with new research papers published trying to help in developing a medication or a vaccine, hoping to end the pandemic.

The immune response towards SARS-CoV-2 remains under focus to try to solve its mystery and use it to protect us from the infection. Antibody response against parts of the coronavirus is now well developed. Recently T-cells response has also been studied and reported in a new study published in Blood.

T-cells are an essential component of the adaptive immune response; they have different functions as killing the infected cells and activating other immune system members.  

The newly published study recognized that the blood of COVID-19 recovered patients has T-cells that recognize viral proteins in SARS-CoV-2, making them immune against the virus.

Image Credit: MattLphotography/Shutterstock.com

Michael Keller, M.D., a pediatric immunology specialist at Children's National Hospital, who led the study, said, "We found that many people who recover from COVID-19 have T-cells that recognize and target viral proteins of SARS-CoV-2, giving them immunity from the virus because those T-cells are primed to fight it,"

They collected those T-cells from different recovered donors, multiplied them in the lab to test their response against infection with SARS-CoV-2. The T-cells effectively targeted viral proteins that are important to its function, proving that they can help fight SARS-CoV-2 infection.

The researchers in the Cellular Therapy Program at Children's National suggested using T-cells immunotherapy to protect immuno-compromised patients as cancer patients or patients with blood disorders, as they can not fight the virus independently can get reinfected after recovery. The hypothesis was based on evidence from previous clinical trials that used trained T-cells to target viruses as Epstein-Barr virus.

"We know that patients who have immune deficiencies as a result of pre-existing conditions or following bone marrow or solid organ transplant are extremely vulnerable to viruses like SARS-CoV-2," says Catherine Bollard, M.D., M.B.Ch.B., senior author of the study and director of the novel cell therapies program and the Center for Cancer and Immunology Research at Children's National. "We've seen that these patients are unable to easily clear the virus on their own, and that can prevent or delay needed treatments to fight cancer or other diseases. This approach could serve as a viable option to protect or treat them, especially since their underlying conditions may make vaccines for SARS-CoV-2 unsafe or ineffective."

The study also found new ways that the immune system responds to coronavirus SARS-CoV-2, as the T-cells target proteins found on its cell membrane. This finding can redirect the current vaccine researcher's focus from targeting spike proteins, which help the virus penetrate host cells to target membrane proteins.

Watch the video below to learn about the structure of COVID-19.

Sources: Science Daily, Blood

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
JAN 11, 2021
Immunology
Can Immune cells contribute to Lung Diseases Severity?!
JAN 11, 2021
Can Immune cells contribute to Lung Diseases Severity?!
Macrophages are a type of immune cell that can detect and destruct bacteria, viruses, and harmful materials. They a ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
APR 23, 2021
Microbiology
A Causal Connection Between C-Section Births & Food Allergies
APR 23, 2021
A Causal Connection Between C-Section Births & Food Allergies
The microbes that live in the human gut have a powerful influence on our health, and that microbial community is with us ...
APR 27, 2021
Neuroscience
Leaky Blood-Brain Barrier Linked to Schizophrenia
APR 27, 2021
Leaky Blood-Brain Barrier Linked to Schizophrenia
Researchers from the University of Pennsylvania have found that people with schizophrenia may have a more permeable bloo ...
MAY 13, 2021
Immunology
Tumors Hide From the Immune System by Masquerading as Baby Cells
MAY 13, 2021
Tumors Hide From the Immune System by Masquerading as Baby Cells
The immune system is programmed to recognize foreign bodies as potentially dangerous, promptly removing them before the ...
MAY 13, 2021
Immunology
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
MAY 13, 2021
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
Salmonella infections are a massive problem—Over 95 million people are affected by this foodborne illness every ye ...
Loading Comments...